Susquehanna International Group’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-14,600
Closed -$55.2K 12933
2025
Q3
$55.2K Buy
+14,600
New +$49.6K ﹤0.01% 11830
2023
Q2
Sell
-18,400
Closed -$63.7K 12571
2023
Q1
$63.7K Buy
18,400
+6,800
+59% +$32.9K ﹤0.01% 11582
2022
Q4
$48.5K Buy
+11,600
New +$43.9K ﹤0.01% 11417
2022
Q2
Sell
-34,000
Closed -$552K 13372
2022
Q1
$552K Buy
34,000
+29,300
+623% +$751K ﹤0.01% 8725
2021
Q4
$223K Sell
4,700
-29,500
-86% -$1.77M ﹤0.01% 11213
2021
Q3
$2.48M Buy
34,200
+21,300
+165% +$1.54M ﹤0.01% 5372
2021
Q2
$1.08M Buy
12,900
+6,900
+115% +$455K ﹤0.01% 7547
2021
Q1
$291K Buy
+6,000
New +$326K ﹤0.01% 10668

Other funds holding NBP

Susquehanna International Group's NBP Position: Q1 2026 in Review

Susquehanna International Group reduced its NovaBridge Biosciences American Depositary Shares (NBP) stake by 73% in Q1 2026, selling an estimated $116K and leaving 12,817 shares worth $31.5K. The position accounts for ﹤0.01% of the portfolio, ranked #12753.

Susquehanna International Group first reported a position in NBP in Q2 2021 and has held it in 14 quarters since. The position peaked at $922K in Q2 2021. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

  • Susquehanna International Group held 12,817 shares of NovaBridge Biosciences American Depositary Shares worth $31.5K as of Q1 2026.
  • Susquehanna International Group sold 34,662 NovaBridge Biosciences American Depositary Shares shares in Q1 2026, an estimated $116K.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12753 holding.
  • Susquehanna International Group first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and has held it in 14 quarters since.
  • Susquehanna International Group's NovaBridge Biosciences American Depositary Shares position peaked at $922K in Q2 2021.
  • 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.